Ophthalmology Education and CME

My Education
Keep track of all your educational activities here
  • Access activities already in progress
  • See credits earned to date
  • Print certificates
  • Top Picks
    • Practice Profiles: Laser-Assisted Cataract Surgery
    • The Importance of Depth of Focus: Extending Range of Vision with a New Class of IOLs
    • Glaucoma: Novel Mechanisms and Treatments that Target the Elusive IOP
    • When Leaving the Eye

Select a Topic

  • FILTER BY:
cover image
CME

Glaucoma 2017: Controlling IOP and Promoting Adherence through Novel Therapeutics

This activity is supported by an educational grant from Aerie Pharmaceuticals, Inc.

Expiration Date: 2/9/2018
Credit Type(s): CME | Credit: 1

Glaucoma is currently the second leading cause of blindness throughout the world. The goal of glaucoma treatment is to stop or slow disease progression. Current glaucoma…

go to activity»
j142
CME

Non-infectious Uveitis: Moving Beyond the Standard of Care with an Eye on the Evidence

This activity is supported by educational grants from AbbVie, Inc.

Expiration Date: 1/10/2018
Credit Type(s): CME | Credit: 0.75

Uveitis is one of the leading causes of preventable blindness worldwide with a prevalence in the US of about 38 cases per 100,000 people. However, uveitis is commonly…

go to activity»
Uveitis
CME

Case Discussions in the Diagnosis and Evolving Management of Posterior Noninfectious Uveitis

Expiration Date: 12/31/2017
Credit Type(s): AMA PRA Category 1 CreditTM | Credit: 1.5

There are new developments in the management of posterior noninfectious uveitis. Keep up-to-date with this case-based CME activity, which provides relevant and practical…

go to activity»
Best of Retina Forum 2016 - Diabetic Retinopathy: A Revolution in Treatment Options
CME

Best of Retina Forum® 2016 - Diabetic Retinopathy: A Revolution in Treatment Options

This activity is supported by educational grants from Carl Zeiss Meditec, Inc. and Regeneron Pharmaceuticals, Inc.

Expiration Date: 12/12/2017
Credit Type(s): CME | Credit: 2

Diabetic retinopathy (DR) is an insidious, progressive disease. Diabetic macular edema (DME), which can occur at any stage of DR, is the most frequent cause of blindness…

go to activity»
Glaucoma
CME

Glaucoma: Novel Mechanisms and Treatments that Target the Elusive IOP

This activity is supported by an educational grant from Bausch + Lomb.

Expiration Date: 12/12/2017
Credit Type(s): CME | Credit: 1

Glaucoma is currently the second leading cause of blindness throughout the world. The goal of glaucoma treatment is to stop or slow disease progression. Current glaucoma…

go to activity»
Cataract360TM – Fundamentals, Techniques, & Technology: Volume 1, Number 3
CME

Cataract360TM - Fundamentals, Techniques, & Technology: Volume 1, Number 3

This activity is supported by educational grants from Abbott Medical Optics, Alcon Research, Ltd., and Bausch + Lomb.

Expiration Date: 9/25/2017
Credit Type(s): CME | Credit: 1.25

Successful cataract surgery is a multifactorial process that relies on numerous interconnected assessment, planning, and execution procedures. Phacodynamics, the effects…

go to activity»
m238 activity listing s

Practice Profiles: Laser-Assisted Cataract Surgery

This activity is sponsored by Abbott.

February 8, 2017

Four physicians present their experience with laser-assisted cataract surgery. © 2016 Abbott Medical Optics Inc….

go to activity»
Uveitis
CME

Perspectives From Around the World in the Management of Chronic Posterior Noninfectious Uveitis

Expiration Date: 12/31/2017
Credit Type(s): AMA PRA Category 1 CreditTM | Credit: 1.5

This CME program brings you valuable perspectives from international uveitis experts. Watch and listen to them cover the diagnosis and recent developments in the…

go to activity»
The Importance of Depth of Focus: Extending Range of Vision with a New Class of IOLs

The Importance of Depth of Focus: Extending Range of Vision with a New Class of IOLs

This activity is supported by an independent third-party grant from Abbott Medical Optics.

December 13, 2016

IOL implantation has transformed over the past several decades from an unconventional procedure to standard practice during cataract surgery. As IOLs grew in popularity…

go to activity»
J239
CME

When Leaving the Eye "High and Dry" is Not the Solution- Experts Converge

This activity is supported by an independent medical educational grant from Shire.

Expiration Date: 12/12/2017
Credit Type(s): CME | Credit: 1

Dry eye disease (DED) is a condition of the ocular surface in which multiple factors are responsible for the disturbance of the stability of tear film, leading to…

go to activity»
Cataract360 - Fundamentals, Techniques, & Technology: Volume 1, Number 4
CME

Cataract360TM - Fundamentals, Techniques, & Technology: Volume 1, Number 4

This activity is supported by educational grants from Abbott Medical Optics, Alcon Research, Ltd., and Bausch + Lomb.

Expiration Date: 11/25/2017
Credit Type(s): CME | Credit: 1.25

Successful cataract surgery is a multifactorial process that relies on numerous interconnected assessment, planning, and execution procedures. Phacodynamics, the effects…

go to activity»
Combining strategies in the counseling and care of the cataract patient

Combining strategies in the counseling and care of the cataract patient

This activity is sponsored by Bausch + Lomb.

September 23, 2016

Cataract surgery causes inflammation; therefore, treatment of inflammation is important to the patient. A panel of leading ophthalmologists met during Hawaiian Eye 2016…

go to activity»
cover image
CME

Glaucoma 2017: Controlling IOP and Promoting Adherence through Novel Therapeutics

This activity is supported by an educational grant from Aerie Pharmaceuticals, Inc.

Expiration Date: 2/9/2018
Credit Type(s): CME | Credit: 1

Glaucoma is currently the second leading cause of blindness throughout the world. The goal of glaucoma treatment is to stop or slow disease progression. Current glaucoma…

go to activity»
m238 activity listing s

Practice Profiles: Laser-Assisted Cataract Surgery

This activity is sponsored by Abbott.

February 8, 2017

Four physicians present their experience with laser-assisted cataract surgery. © 2016 Abbott Medical Optics Inc….

go to activity»
j142
CME

Non-infectious Uveitis: Moving Beyond the Standard of Care with an Eye on the Evidence

This activity is supported by educational grants from AbbVie, Inc.

Expiration Date: 1/10/2018
Credit Type(s): CME | Credit: 0.75

Uveitis is one of the leading causes of preventable blindness worldwide with a prevalence in the US of about 38 cases per 100,000 people. However, uveitis is commonly…

go to activity»
Uveitis
CME

Perspectives From Around the World in the Management of Chronic Posterior Noninfectious Uveitis

Expiration Date: 12/31/2017
Credit Type(s): AMA PRA Category 1 CreditTM | Credit: 1.5

This CME program brings you valuable perspectives from international uveitis experts. Watch and listen to them cover the diagnosis and recent developments in the…

go to activity»
Uveitis
CME

Case Discussions in the Diagnosis and Evolving Management of Posterior Noninfectious Uveitis

Expiration Date: 12/31/2017
Credit Type(s): AMA PRA Category 1 CreditTM | Credit: 1.5

There are new developments in the management of posterior noninfectious uveitis. Keep up-to-date with this case-based CME activity, which provides relevant and practical…

go to activity»
The Importance of Depth of Focus: Extending Range of Vision with a New Class of IOLs

The Importance of Depth of Focus: Extending Range of Vision with a New Class of IOLs

This activity is supported by an independent third-party grant from Abbott Medical Optics.

December 13, 2016

IOL implantation has transformed over the past several decades from an unconventional procedure to standard practice during cataract surgery. As IOLs grew in popularity…

go to activity»
Best of Retina Forum 2016 - Diabetic Retinopathy: A Revolution in Treatment Options
CME

Best of Retina Forum® 2016 - Diabetic Retinopathy: A Revolution in Treatment Options

This activity is supported by educational grants from Carl Zeiss Meditec, Inc. and Regeneron Pharmaceuticals, Inc.

Expiration Date: 12/12/2017
Credit Type(s): CME | Credit: 2

Diabetic retinopathy (DR) is an insidious, progressive disease. Diabetic macular edema (DME), which can occur at any stage of DR, is the most frequent cause of blindness…

go to activity»
J239
CME

When Leaving the Eye "High and Dry" is Not the Solution- Experts Converge

This activity is supported by an independent medical educational grant from Shire.

Expiration Date: 12/12/2017
Credit Type(s): CME | Credit: 1

Dry eye disease (DED) is a condition of the ocular surface in which multiple factors are responsible for the disturbance of the stability of tear film, leading to…

go to activity»
Glaucoma
CME

Glaucoma: Novel Mechanisms and Treatments that Target the Elusive IOP

This activity is supported by an educational grant from Bausch + Lomb.

Expiration Date: 12/12/2017
Credit Type(s): CME | Credit: 1

Glaucoma is currently the second leading cause of blindness throughout the world. The goal of glaucoma treatment is to stop or slow disease progression. Current glaucoma…

go to activity»
Cataract360 - Fundamentals, Techniques, & Technology: Volume 1, Number 4
CME

Cataract360TM - Fundamentals, Techniques, & Technology: Volume 1, Number 4

This activity is supported by educational grants from Abbott Medical Optics, Alcon Research, Ltd., and Bausch + Lomb.

Expiration Date: 11/25/2017
Credit Type(s): CME | Credit: 1.25

Successful cataract surgery is a multifactorial process that relies on numerous interconnected assessment, planning, and execution procedures. Phacodynamics, the effects…

go to activity»
Cataract360TM – Fundamentals, Techniques, & Technology: Volume 1, Number 3
CME

Cataract360TM - Fundamentals, Techniques, & Technology: Volume 1, Number 3

This activity is supported by educational grants from Abbott Medical Optics, Alcon Research, Ltd., and Bausch + Lomb.

Expiration Date: 9/25/2017
Credit Type(s): CME | Credit: 1.25

Successful cataract surgery is a multifactorial process that relies on numerous interconnected assessment, planning, and execution procedures. Phacodynamics, the effects…

go to activity»
Combining strategies in the counseling and care of the cataract patient

Combining strategies in the counseling and care of the cataract patient

This activity is sponsored by Bausch + Lomb.

September 23, 2016

Cataract surgery causes inflammation; therefore, treatment of inflammation is important to the patient. A panel of leading ophthalmologists met during Hawaiian Eye 2016…

go to activity»
Gateways to Cataract Refractive Surgery: Managing astigmatism and beyond

Gateways to Cataract Refractive Surgery: Managing Astigmatism and Beyond

This promotional activity is sponsored by Alcon Laboratories, Inc. All faculty members are paid Alcon consultants.

September 8, 2016

During Hawaiian Eye 2016, KOLs gathered for an Industry Expert Theater panel discussion, sponsored by Alcon Laboratories, Inc. and moderated by Stephen S. Lane, MD, on…

go to activity»
Practice Profiles in Pre-Loaded IOL Delivery

Practice Profiles in Pre-Loaded IOL Delivery

This activity is produced by SLACK Incorporated and sponsored by Alcon Laboratories, Inc. Participating physicians are paid consultants of Alcon Laboratories, Inc.

August 23, 2016

Gain expert insight as leading physicians discuss the benefits of using a pre-loaded IOL delivery system in their practices….

go to activity»
IOLMaster 700

Read what renowned experts have to say about: repeatability & performance, cataract penetration rate and the potential of SWEPT Source OCT technology in biometry….

go to activity»
j297 cover image
CME

Under Pressure: Assessing Novel Treatment Options for Glaucoma

This activity is supported by an educational grant from Bausch + Lomb.

Expiration Date: 8/31/2017
Credit Type(s): CME | Credit: 1

Glaucoma is currently the second leading cause of blindness throughout the world. The goal of glaucoma treatment is to stop or slow disease progression. Current glaucoma…

go to activity»
Patient profiles on anti-infectives

Patient Profiles on Anti-Infectives

This activity is sponsored by Bausch + Lomb.

June 30, 2016

Learn as leading experts share their perspective on treating patients with bacterial conjunctivitis and herpetic keratitis….

go to activity»
Cataract360--Fundamentals, Techniques, & Technology: Volume 1, Number 2
CME

Cataract360TM - Fundamentals, Techniques, & Technology: Volume 1, Number 2

This activity is supported by educational grants from Abbott Medical Optics, Alcon Research, Ltd., and Bausch + Lomb.

Expiration Date: 7/25/2017
Credit Type(s): CME | Credit: 1.25

This issue focuses on biometry and IOL calculations, IOL power diagnostics and surgical guidance systems, manual capsulorhexis techniques, and misaligned toric IOLs.

go to activity»
	 J094 Activity Type	 Article/E-publication Activity Title	 Cataract360 – Fundamentals, Techniques, & Technology: Volume 1, Number 1
CME

Cataract360TM - Fundamentals, Techniques, & Technology: Volume 1, Number 1

This activity is supported by educational grants from Abbott Medical Optics, Alcon Research, Ltd., and Bausch + Lomb.

Expiration Date: 5/25/2017
Credit Type(s): CME | Credit: 1.25

This issue focuses on femtosecond laser cataract surgery, optimizing astigmatic correction, wound architecture and construction, light-adjustable IOLs, and negative…

go to activity»
The Importance of NSAIDS After Cataract Surgery: Considerations on Penetration, Efficacy, Pharmacy Fills and Callbacks

The goal of cataract surgery is to improve vision for patients, so ophthalmologists need more than just a quality IOL and the latest surgical tools on hand. For patients…

go to activity»
MicroPulse

MicroPulse Laser Therapy in the Management of DME

This promotional educational activity is presented by IRIDEX.

April 4, 2016

Watch as Allen C. Ho, MD; Robert L. Avery, MD; Lawrence S. Morse, MD, PhD; Elias Reichel, MD present topics focusing on effective laser treatment in the management of…

go to activity»
Scott
CME

Key Components in the Design and Execution of a Successful Clinical Trial

This activity is supported by educational grants from Allergan, Inc.; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc.

Expiration Date: 3/25/2017
Credit Type(s): CME | Credit: 0.25

The advent of intravitreal therapies to treat retinal diseases has revolutionized the management of retinal pathology. Reviewing the major trials and their subsequent…

go to activity»
waheed
CME

Imaging Modalities in Clinical Trials

This activity is supported by educational grants from Allergan, Inc.; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc.

Expiration Date: 3/25/2017
Credit Type(s): CME | Credit: 0.5

The advent of intravitreal therapies to treat retinal diseases has revolutionized the management of retinal pathology. Reviewing the major trials and their subsequent…

go to activity»
Flynn
CME

Clinical Trials in Diabetic Retinopathy

This activity is supported by educational grants from Allergan, Inc.; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc.

Expiration Date: 3/25/2017
Credit Type(s): CME | Credit: 0.5

The advent of intravitreal therapies to treat retinal diseases has revolutionized the management of retinal pathology. Reviewing the major trials and their subsequent…

go to activity»
Ip
CME

Central and Branch Retinal Vein Occlusion Clinical Trials: A Comprehensive Review

This activity is supported by educational grants from Allergan, Inc.; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc.

Expiration Date: 3/25/2017
Credit Type(s): CME | Credit: 0.5

The advent of intravitreal therapies to treat retinal diseases has revolutionized the management of retinal pathology. Reviewing the major trials and their subsequent…

go to activity»
Singh
CME

Comparative Treatment Trials for Wet AMD: A Comprehensive Review

This activity is supported by educational grants from Allergan, Inc.; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc.

Expiration Date: 3/25/2017
Credit Type(s): CME | Credit: 0.5

The advent of intravitreal therapies to treat retinal diseases has revolutionized the management of retinal pathology. Reviewing the major trials and their subsequent…

go to activity»
Moshfeghi
CME

Wet Macular Degeneration: A Review of Pivotal Clinical Trials

This activity is supported by educational grants from Allergan, Inc.; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc.

Expiration Date: 3/25/2017
Credit Type(s): CME | Credit: 0.5

The advent of intravitreal therapies to treat retinal diseases has revolutionized the management of retinal pathology. Reviewing the major trials and their subsequent…

go to activity»
Boyer
CME

Conducting Macular Clinical Trials in a Private Practice Environment

This activity is supported by educational grants from Allergan, Inc.; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc.

Expiration Date: 3/25/2017
Credit Type(s): CME | Credit: 0.25

The advent of intravitreal therapies to treat retinal diseases has revolutionized the management of retinal pathology. Reviewing the major trials and their subsequent…

go to activity»
Video Innovator Series

Video Innovator Series

This promotional content is produced by SLACK Incorporated and sponsored by Alcon Laboratories, Inc.

March 22, 2016

Experts share their perspective on treating pain and inflammation associated with cataract surgery….

go to activity»
J899 Cover Image
CME

Emerging Options for Day-in and Day-out IOP Control

This activity is supported by an educational grant from Bausch + Lomb.

Expiration Date: 3/29/2017
Credit Type(s): CME | Credit: 1

Unfortunately, even with appropriate use of currently available medications, many people with glaucoma will still experience vision loss. Intraocular pressure (IOP) is…

go to activity»
New Treatment Paradigms for Diabetic Retinopathy: Current Status and Applications for Practice
CME

New Treatment Paradigms for Diabetic Retinopathy: Current Status and Applications for Practice

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 3/10/2017
Credit Type(s): CME | Credit: 1

Despite a number of effective treatment options, diabetic eye disease is a leading cause of vision loss in the United States, in part because many patients are not…

go to activity»
J936
CME

Early to Late Age-related Macular Degeneration: Optimizing Assessment and Management

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 3/8/2017
Credit Type(s): CME | Credit: 1

Age-related macular degeneration (AMD) is a common eye condition and a leading cause of vision loss among people aged 50 years and older. Diagnosing AMD involves a…

go to activity»
J916 Cover
CME

Redefining the Role of Photodynamic Therapy in Neovascular Age-related Macular Degeneration

This activity is supported by an educational grant from Bausch + Lomb.

Expiration Date: 3/4/2017
Credit Type(s): CME | Credit: 1

Photodynamic therapy (PDT), with use of verteporfin as a photosensitizer, is one of the few therapies that has been shown to effectively slow the progression of the…

go to activity»
J930
CMEVIDEO

Current Insights: Applying New Data to Optimize Treatment of Diabetic Retinal Disease

This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.

Expiration Date: 3/3/2017
Credit Type(s): CME | Credit: 1

Intravitreal therapy with anti-VEGF agents has rapidly become the new standard of care in diabetic macular edema (DME), and is increasingly recognized as an effective…

go to activity»
j904
CME

Optimizing Ocular Surgery Outcomes with Topical Therapy

This activity is supported by an educational grant from Bausch + Lomb.

Expiration Date: 3/1/2017
Credit Type(s): CME | Credit: 1

Ocular pain and inflammation are common following surgery and may increase the risk of complications, such as cystoid macular edema (CME) and endophthalmitis. However…

go to activity»
Preserving the Ocular Surface: Practice Pearls That Go Beyond Just Scratching the Surface
CME

Preserving the Ocular Surface: Practice Pearls That Go Beyond Just Scratching the Surface

This activity is supported by an educational grant from Alcon Research, LTD., Allergan, Inc., Bausch + Lomb, and Shire.

Expiration Date: 3/13/2017
Credit Type(s): CME | Credit: 1.25

Ocular surface disorders (OSDs) are chronic, progressive, multifactorial conditions with prevalence increasing with age, including dry eye disease (DED). The numerous…

go to activity»
In Focus: Advances in AMD – Current, Emerging, and Future Strategies for the Management of Dry AMD
CME

In Focus: Advances in AMD – Current, Emerging, and Future Strategies for the Management of Dry AMD

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 10/30/2017
Credit Type(s): CME | Credit: 0.5

Dry age-related macular degeneration has proven to be a challenging condition for clinicians, and no pharmaceutical options have been shown to be effective. Dry AMD is a…

go to activity»
Sadda
CME

In Focus: Advances in AMD – Managing Wet AMD in 2014 - What Do the Data Tell Us, and What Don’t They?

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 10/30/2017
Credit Type(s): CME | Credit: 0.5

A number of clinical trials have established the use of anti-VEGF therapy as first-line therapy in the management of wet age-related macular degeneration, and…

go to activity»
Hariprasad
CME

In Focus: Advances in AMD – Clinical Case: Starting therapy in a patient newly diagnosed with wet AMD

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 10/30/2017
Credit Type(s): CME | Credit: 0.25

Successful early treatment of wet age-related macular degeneration offers the best odds for maintaining visual acuity over time. In this activity, Seenu Hariprasad, MD…

go to activity»
boyer
CME

In Focus: Advances in AMD - Clinical Case: Long-term Management of Established Age-related Macular Degeneration

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 10/30/2017
Credit Type(s): CME | Credit: 0.25

Long-term management of wet age-related macular degeneration can be challenging, as medications and dosing schedules that had previously improved visual acuity may lose…

go to activity»
IN FOCUS: Advances in AMD - Strategies and Options in Managing Wet and Dry AMD
CME

IN FOCUS: Advances in AMD - Strategies and Options in Managing Wet and Dry AMD

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 10/27/2017
Credit Type(s): CME | Credit: 0.75

The damage associated with age-related macular degeneration begins before visual symptoms occur, making early diagnosis critical in achieving the best outcomes for…

go to activity»
Blephartis Management

Blepharitis Management: Current Thinking and Clinical Insights

This activity is sponsored by Bausch + Lomb.

July 25, 2014

Blepharitis Management: Current Thinking and Clinical Insights….

go to activity»
activity image
COPECECME

Ocular Surface Diseases, Disorders, & DysfunctionsTM: Volume 2, Number 4

This activity is supported by an educational grant from Shire.

Expiration Date: 11/10/2017
Credit Type(s): COPE / CME | Credit: 1.25

Maintenance of the health of the ocular surface is complex due to numerous potential challenges, including dry eye disease, allergic conjunctivitis, contact lens wear…

go to activity»
j410
COPECECME

Ocular Surface Diseases, Disorders, & DysfunctionsTM: Volume 2, Number 3

This activity is supported by an educational grant from Shire.

Expiration Date: 10/1/2017
Credit Type(s): COPE / CME | Credit: 1.25

Maintenance of the health of the ocular surface is complex due to numerous potential challenges, including dry eye disease, allergic conjunctivitis, contact lens wear…

go to activity»
Facial Rejuvenation

Catch up with three clinicians as they provide insightful information on the topic of facial rejuvenation….

go to activity»
Diabetic Eye Disease: Screening Strategies and Imaging Devices - Issue 1
COPE

Diabetic Eye Disease: Screening Strategies and Imaging Devices - Number 1

This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.

Expiration Date: 9/1/2017
Credit Type(s): COPE | Credit: 1

Diabetic retinopathy (DR) is a major cause of blindness among American adults aged 40 years and older. The prevalence of DR in this population is increasing; it…

go to activity»
J410
COPECECME

Ocular Surface Diseases, Disorders, & DysfunctionsTM: Volume 2, Number 2

This activity is supported by an educational grant from Shire.

Expiration Date: 9/10/2017
Credit Type(s): COPE / CME | Credit: 1.25

Maintenance of the health of the ocular surface is complex due to numerous potential challenges, including dry eye disease, allergic conjunctivitis, contact lens wear…

go to activity»
Ocular Surface Diseases, Disorders, & Dysfunctions: Volume 2, Number 1
COPECECME

Ocular Surface Diseases, Disorders, & DysfunctionsTM: Volume 2, Number 1

This activity is supported by an educational grant from Shire.

Expiration Date: 8/1/2017
Credit Type(s): COPE / CME | Credit: 1.25

Maintenance of the health of the ocular surface is complex due to numer-ous potential challenges, including dry eye disease, allergic conjunctivitis, contact lens wear…

go to activity»
Diabetic Retinopathy: Preferred Practice Patterns in Screening and Management
CMECNECE

Diabetic Retinopathy: Preferred Practice Patterns in Screening and Management

This activity is supported by an educational grant from Regeneron.

Expiration Date: 8/10/2017
Credit Type(s): CME / CNE / AANP / AAPA | Credit: 1.5

Diabetic retinopathy (DR) is a major cause of blindness among American adults aged 40 years and older. The prevalence of DR in this population is increasing; it…

go to activity»